Financial Performance - The company's revenue for the six months ended September 30, 2023, was HKD 24,555,000, representing a 22.0% increase compared to HKD 20,021,000 for the same period last year[4]. - The company reported a loss before tax of HKD 2,145,000 for the six months ended September 30, 2023, which is a 35.7% reduction from a loss of HKD 3,331,000 in the same period last year[4]. - The total comprehensive loss for the six months ended September 30, 2023, was HKD 2,099,000, down from HKD 3,277,000 in the previous year, reflecting a 36.0% improvement[16]. - The company reported a net loss attributable to shareholders of HKD 2,123 thousand for the six months ended September 30, 2023, compared to a loss of HKD 3,305 thousand for the same period in 2022, representing a 35.7% improvement[33]. - Revenue from medical consultation services increased to HKD 589 thousand, up 18.7% from HKD 496 thousand in the previous year[26]. - Total revenue for the six months ended September 30, 2023, was HKD 24,555 thousand, a 22.0% increase compared to HKD 20,021 thousand in the same period of 2022[26]. - The basic loss per share for the six months ended September 30, 2023, was HKD 0.54, compared to HKD 0.83 for the same period last year, showing an improvement in per-share loss metrics[16]. - The company's basic loss per share for the period was HKD 0.54, a reduction of 34.9% from HKD 0.83 in the previous year[73]. Cash Flow and Assets - The operating cash generated for the three months ended September 30, 2023, was HKD 2,831,000, compared to HKD 862,000 for the same period in 2022, indicating a significant improvement[10]. - The company's cash and cash equivalents at the end of the reporting period were HKD 3,351,000, a decrease from HKD 9,751,000 at the end of the previous year[10]. - As of September 30, 2023, total assets amounted to HKD 24,912 thousand, a decrease of 6.7% from HKD 26,713 thousand as of March 31, 2023[18]. - The company reported a decrease in total liabilities to HKD 28,681 thousand as of September 30, 2023, down from HKD 29,291 thousand as of March 31, 2023[18]. - The net asset value as of September 30, 2023, was HKD 9,037 thousand, a decline of 19.0% from HKD 11,160 thousand as of March 31, 2023[18]. - The group’s bank balance and cash as of September 30, 2023, was HKD 3.4 million, a decrease from HKD 5.0 million as of March 31, 2023, with no external borrowings[130]. - Time deposits amounted to HKD 13.6 million as of September 30, 2023, slightly down from HKD 13.9 million as of March 31, 2023[131]. Liabilities and Equity - The net current liabilities of the group were HKD 3.8 million, primarily due to contract liabilities of HKD 18.5 million, which are expected to be fulfilled without cash outflow[12]. - The net current liabilities of the group as of September 30, 2023, stood at HKD 3.8 million, an increase from HKD 2.6 million as of March 31, 2023[130]. - As of September 30, 2023, the total equity of the group was HKD 9.0 million, down from HKD 11.2 million as of March 31, 2023[130]. - The company has no interest-bearing borrowings, resulting in a capital debt ratio of zero as of September 30, 2023[76]. Operational Highlights - The company continues to focus on providing medical consultation services, prescription and dispensing services, and treatment services as its primary revenue sources[13]. - The group operates a single business segment focused on medical consultation services, prescription and dispensing services, and treatment services[46]. - The group operates two "Medicskin" brand medical skin care centers in prime locations in Hong Kong, focusing on treating skin diseases and improving customer appearance[67]. - The group continues to face intense competition and rising operational costs, impacting consumer sentiment amid ongoing economic challenges[45]. Employee and Costs - Employee costs increased to HKD 12,511 thousand for the six months ended September 30, 2023, up from HKD 10,420 thousand in the previous year, reflecting a 20.0% rise[30]. - The group employed 28 full-time and 16 part-time employees as of September 30, 2023, with total employee costs amounting to HKD 12.5 million for the six months ended September 30, 2023, compared to HKD 10.4 million for the same period in 2022[115]. - Employee costs rose by HKD 2.1 million or 20.1% to HKD 12.5 million, primarily due to increased salaries and performance bonuses linked to revenue growth[92]. Governance and Compliance - The company has maintained its accounting policies consistent with those used in the preparation of the financial statements for the year ended March 31, 2023[11]. - The audit committee reviewed the group's unaudited interim financial statements for the six months ended September 30, 2023, and found them compliant with applicable accounting standards and GEM listing rules[111]. - The company has adopted corporate governance practices in accordance with the GEM listing rules and has complied with them during the reporting period[108]. - The board of directors believes that the current structure does not undermine the balance of power and authority between the board and the management of the group[119]. Future Outlook - The company remains cautiously optimistic about future performance, anticipating a recovery in sales due to the resumption of normal social and economic activities[90]. - The company anticipates that the application of new accounting standards will not have a significant impact on its financial statements in the foreseeable future[23]. Dividends and Share Options - The company did not declare an interim dividend for the six months ended September 30, 2023, consistent with the previous year[32]. - The company has adopted a share option scheme since December 3, 2014, to reward and/or incentivize eligible individuals for their contributions to the group[115]. - There were no share options granted, exercised, lapsed, or cancelled during the six months ended September 30, 2023[122]. Related Party Transactions - The group has not entered into any transactions with related parties during the six months ended September 30, 2023[43]. - The group reported no individual customer contributing over 10% of total revenue during the six months ended September 30, 2023[48].
密迪斯肌(08307) - 2024 - 中期财报